Proposal The Third Edition November 2010
Benchmarking on PAP and Paracetamol Production in China Researched & Prepared by: Guangzhou CCM Information Science & Technology Co., Ltd. Guangzhou, P. R. China
CCM Data & Primary Intelligence Benchmarking on PAP and Paracetamol Production in China Proposal – The Third Edition November 2010
1.
Introduction
Paracetamol, short for para-acetamino phenol, plays an important role in NSAIDs, namely non-steroidal anti-inflammatory drugs. And para-amino phenol (PAP) is the key raw material for paracetamol production. In 2008, CCM has carried out benchmarking on PAP and paracetamol production in China (the second edition). And after two years, with more attention on environment from government and technological improvement in production, the PAP and paracetamol production has changed much in China. In this report, CCM will survey Bengbu Bayi (the only PAP producer adopting catalytic hydrogenation of p-nitrophenol technology in China), Taixing Yangtze, Liaoning Shixing (top two PAP producers in terms of capacity adopting iron reduction of p-nitrochlorobenzene technology) to replace PAP producers in last edition (Jiangsu Zhongming, Liaoning Tianbao and Liaoning Jinhua), and add Zhejiang Kangle (the third largest paracetamol producers in China) in paracetamol benchmarking. In addition, the future of paracetamol, PAP and its upstream industry and the government's support in China will be revealed in this report. CCM will also find out the alternative replacement product for paracetamol, i.e. and the threat product for APAP in the future. ž
What are the aims of the report?
-
Brief introduction to PAP and paracetamol industry in China
-
Governmental policies on PAP & paracetamol industry in China
-
Introduction to processes for PAP and paracetamol production
-
Most popular methods of PAP and paracetamol in China
-
Financial analysis of target PAP and paracetamol producers
-
Production cost analysis on target PAP and paracetamol producers
-
The future of paracetamol, PAP and its upstream industry
-
The alternative replacement product for paracetamol, i.e. and the threat product for paracetamol in the future
Website: http://www.cnchemicals.com Tel: +86-20-3761 6606
Email: econtact@cnchemicals.com Fax: +86-20-3761 6968
CCM Data & Primary Intelligence 他
What will CCM summit to clients?
-
Independent and authoritative research report in Word-format with around 100-150 pages
-
Over 50 primary tables & 15 figures from a new benchmarking research survey to ensure
unrivalled details and most up-to-date info about the market; -
Benchmarking data of all target producers in Excel-format
2.
Scopes of investigation
The research of benchmarking on PAP and paracetamol production mainly focuses on China, covering: 他
Participants:
-
Producers
-
Raw materials suppliers
-
Technology researchers
他
PAP and paracetamol market
-
Production
-
Raw material supply
-
Technologies
-
Forecast
Website: http://www.cnchemicals.com Tel: +86-20-3761 6606
Email: econtact@cnchemicals.com Fax: +86-20-3761 6968
CCM Data & Primary Intelligence 3.
Main content Benchmarking on PAP and Paracetamol Production in China
Part
Content
Remark (compared with last edition)
Executive summary Introduction and methodologies I
Review of PAP & paracetamol industry
I-1
Brief introduction to paracetamol industry in China
I-2
Brief introduction to PAP industry in China
I-3
Governmental policies on PAP & paracetamol industry in China
Newly added
II
Brief introduction to various technologies of PAP and paracetamol in China
II-1
Introduction to processes for PAP production
II-1.1
Industrialized technologies of PAP
Update, concerning on the latest research in China
Update
- Iron reduction of p-nitrophenol - Catalytic hydrogenation of p-nitrophenol - Catalytic hydrogenation of nitrobenzene II-1.2
Technologies under research - Electrolytic reduction of nitrobenzene - Other findings
II-1.3
Comparison among the above four technologies
II-2
Introduction to processes for paracetamol production
II-2.1
One-step method
II-2.2
Two-step method
III
Detailed introduction to currently most popular methods of PAP and paracetamol
III-1
Technology for PAP
III-1.1
Description of production process and theoretical model of raw materials by iron reduction technology
III-1.2
Description of production process and theoretical model of raw materials by nitrobenzene catalytic hydrogenation technology
III-2
Technology for paracetamol
III-2.1
Brief description of production process
III-2.2
Flow chart of paracetamol production
III-2.3
Theoretical model of raw materials
IV
Estimation on cost and profit of PAP and paracetamol
IV-1
In PAP enterprises
IV-1.1
Taixing Yangtze (adopting PNCB technology)
Update
Newly add
- Basic situation in Taixing Yangtze - Financial analysis of Taixing Yangtze in 2009 - Estimation on raw material cost - Estimation on manufacturing cost - Estimation on management cost Website: http://www.cnchemicals.com Tel: +86-20-3761 6606
Email: econtact@cnchemicals.com Fax: +86-20-3761 6968
CCM Data & Primary Intelligence - Estimation on total production cost - Estimation on profit IV-1.2
Liaoning Shixing (adopting PNCB technology)
Newly add
- Basic situation in Liaoning Shixing Liaoning Shixing and Liaoning Tianbao are the only two PAP producers in Huludao.
- Financial analysis of Liaoning Shixing in 2009 - Estimation on raw material cost - Estimation on manufacturing cost - Estimation on management cost - Estimation on total production cost - Estimation on profit IV-1.3
Bengbu Bayi (adopting catalytic hydrogenation of p-nitrophenol technology)
Newly add
- Basic situation in Bengbu Bayi - Financial analysis of Bengbu Bayi in 2009 - Estimation on raw material cost - Estimation on manufacturing cost - Estimation on management cost - Estimation on total production cost - Estimation on profit IV-1.4
Comparison among above three producers
IV-2
In paracetamol enterprises
IV-2.1
Lu’an Pharm
Update Update
- Basic situation in Lu’an Pharm - Financial analysis of Lu’an Pharm in 2009 - Estimation on raw material cost - Estimation on manufacturing cost - Estimation on management cost - Estimation on total production cost - Estimation on profit IV-2.2
Hebei Jiheng - Basic situation in Hebei Jiheng
Update
- Actual flowchart in Hebei Jiheng - Financial analysis of Hebei Jiheng in 2009 - Estimation on raw material cost - Estimation on manufacturing cost - Estimation on management cost - Estimation on total production cost - Estimation on profit IV-2.3
Zhejiang Kangle
Newly add
- Basic situation in Zhejiang Kangle - Financial analysis of Zhejiang Kangle in 2009 - Estimation on raw material cost - Estimation on manufacturing cost - Estimation on management cost
Website: http://www.cnchemicals.com Tel: +86-20-3761 6606
Email: econtact@cnchemicals.com Fax: +86-20-3761 6968
CCM Data & Primary Intelligence - Estimation on total production cost - Estimation on profit IV-2.4
Comparison among above three producers
Update
IV-2.5
Nanjing Petrochemical
Newly add
- Basic situation in Nanjing Petrochemical Nanjing Petrochemical doesn’t produce PAP, while it has a paracetamol project, whose detailed information we will need to confirm in this report.
- Process on its paracetamol project
V
Forecast on PAP & paracetamol industry in China
V-1
Forecast on market (Paracetamol & PAP and its upstream industry)
V-2
Forecast on technology
V-3
Alternative replacement products for paracetamol in the future
Newly add
VI
Site visit reports
Update
¾
Difficulties and solutions Item
Financial analysis
Update
Difficulty
Solution
Most producers are not listed companies, and
Financial data will be purchased from
their
third party, and then given the analysis,
financial
Meanwhile,
data
since
are
these
not
transparent.
enterprises
also
produce other products, financial data can’t
which is only a reference to benchmark PAP or paracetamol production.
completely reflect the PAP or paracetamol production. PAP producer
According to our last visit experience, It is
CCM will endeavor to conduct the site
difficult to site visit Liaoning Shixing and
visit on these two producers. Or Lu’an
Bengbu Bayi, especially for Bengbu Bayi, the
Pharm and Changshu Fengyi will be
only
alternatives for PAP producers. (except
PAP
producer
adopting
catalytic
hydrogenation of p-nitrophenol technology in
Jiangsu
China, who keeps their technology confidential.
Tianbao, these two companies rank
Zhongming
and
Liaoning
after above target producers in terms of capacity) Paracetamol producer
We can not be sure to site visit all these three
Tianjin Bofa and Bayi Pharm will be
producers to get the first-hand data.
alternatives for paracetamol producer survey. (these two companies rank after above target producers in terms of capacity)
Website: http://www.cnchemicals.com Tel: +86-20-3761 6606
Email: econtact@cnchemicals.com Fax: +86-20-3761 6968
CCM Data & Primary Intelligence 4.
Methodology and sources Data sources
Periodicals, magazines, journals, Internet, CCM database, other public media or third party database
Producers, raw materials suppliers, associations, industrial experts, etc. Financial data, journals, etc.
Step
Desk research
Telephone interview
ValoTracer
Financial analysis Quantitative & qualitative analysis, discussion, forecast,etc.
Site visit
Report generation
Data to be collected and compiled by CCM will be sourced from: -
CCM database (mainly based on ValoTracer)
-
Published articles from Chinese and foreign periodicals, magazines, journals, third-party database
-
Telephone interviews with Chinese producers, raw materials suppliers
-
Site visits on producers
-
Comments from industrial experts
-
Information from the Internet
-
Other public media
The research for the report will consist of five stages: 他 Stage 1 Desk research The sources of desk research are various, including Chinese and foreign published magazines, journals, association seminars as well as information from the Internet. A lot of work will go into compilation and analysis of the obtained information. 他
Stage 2 Telephone interviews
CCM will carry out extensive telephone interviews in order to survey the actual situation in PAP and paracetamol production. Interviewees will cover: -
Key producers
Website: http://www.cnchemicals.com Tel: +86-20-3761 6606
Email: econtact@cnchemicals.com Fax: +86-20-3761 6968
CCM Data & Primary Intelligence -
Raw material suppliers Some associations Researchers and research institutes
他
Stage 3 Financial analysis
Financial data in 2009 will be gotten from third-party database suppliers or annual report about listed companies. And then financial analysis will be necessary to further understand financial situation about target producers. Finally, the advantages and disadvantages will be revealed after comparison among the target producers who manufacture the same product.
Of course, financial analysis is only a reference to benchmark PAP or paracetamol production since these enterprises not only produce PAP or paracetamol, but also other products. 他
Stage 4 Site visits
CCM will carry out site visits and face-to-face interviews with all target producers which will be identified through telephone interviews. The site visits will be presented in the finial report. 他
Stage 5 Report generation
Logical analysis and scientific ratiocination will be conducted to generate the report. All the data and findings obtained in the above four stages will be presented in the report clearly. 5.
Submission time
CCM schedules to finish this report in 2 months after you order.
Website: http://www.cnchemicals.com Tel: +86-20-3761 6606
Email: econtact@cnchemicals.com Fax: +86-20-3761 6968
Related products: Benchmarking on PAP and Paracetamol Production in China (Second edition) The p-Amino Phenol (PAP) Industry in China (Fourth edition) The Paracetamol Industry in China (Fifth edition)
Copyright Š Guangzhou CCM Information Science & Technology Co., Ltd. Any publication, distribution or copying of the content is prohibited. Address: 17th Floor, Huihua Commercial & Trade Building, No.80 Xianlie Zhong Road Guangzhou, 510070, P. R. China Tel: +86-20-37616606 Fax: +86-20-37616968 E-mail: econtact@cnchemicals.com Website: www.cnchemicals.com